Annual Report 2013

Total Page:16

File Type:pdf, Size:1020Kb

Annual Report 2013 Onderzoekschool Oncologie Amsterdam Oncology Graduate School Amsterdam Annual Report 2013 Address Oncology Graduate School Amsterdam OOA VU medisch centrum Kamer PK 7Z 182 De Boelelaan 1117 1081 HV Amsterdam phone : 020-4443113 e-mail : [email protected] website : www.ooa-graduateschool.org Contents Preface 5 1 Board and organization 9 2 General report 13 3 Educational activities 19 4 PhD research program 25 5 Awards 49 Annex 1 Faculty and staff 53 Annex 2 International visitors 67 Annex 3 PhD theses completed 71 Annex 4 Scientific publications 81 Oncology Graduate School Amsterdam OOA preface Preface An important mission of the Oncology Graduate activities, including specialized training courses, School Amsterdam (Onderzoekschool Oncologie seminars and meet-the-expert sessions. Besides Amsterdam – OOA) is to organize the education in this, major effort is put into the organization of an basic and clinical cancer research of the graduate annual graduate student retreat. This retreat students in the Amsterdam region, and to ensure teaches skills in reporting, presenting and proper supervision and mentoring of graduate collaboration activities. students. The OOA graduate students are scientist- in-training who receive additional theoretical and This report presents the activities and scientific practical education on various subjects related to output of OOA in 2013. It includes detailed listings cancer. of our educational activities, such as training programs, and an overview of the scientific output, OOA is a joint venture of the medical faculties the including listings of PhD theses completed and VU University Medical Center (VUmc) and the scientific papers published throughout 2013. Academic Medical Center (AMC), of the VU University Amsterdam (Vrije Universiteit - VU) and the University of Amsterdam (Universiteit van Amsterdam- UvA), respectively, and the Netherlands Cancer Institute (Nederlands Kanker Instituut - NKI). These organizations strive for excellence in research and education in oncology, the realization of which is promoted by their participation in OOA. The OOA research program ranges from basic molecular biology to clinical bedside research. It includes, for instance, fundamental studies on cellular signal transduction and the control of gene Executive Directors, expression, but also clinical trials of new (combination) approaches and the development of Prof. dr. A.W. Griffioen (VUMC) new tools to evaluate the quality of life in cancer Prof. dr. T.K. Sixma and prof. dr. H. te Riele (NKI) patients. OOA organizes a range of educational Dr. M. Spaargaren (UvA) Preface - 7 8 - Preface Oncology Graduate School Amsterdam OOA board and organization 1 1. Board and organization Board Participating institutes Prof.dr. A. Berns, chairman VU University Amsterdam (VU)/ Prof.dr. S. Rodenhuis VU University Medical Center (VUmc) Prof.dr. C.J.L.M. Meijer Administrative center Prof.dr. P. Postmus Contact / secretariat: dr. E.M. Ruhé-Hoogervorst Prof.dr. C.E.E. Konings De Boelelaan 1117 Prof.dr. D.J. Richel 1081 HV Amsterdam phone : 020-4443113 fax : 020-4442964 Executive directors email : [email protected] Prof. dr. A.W. Griffioen, chairman University of Amsterdam (UvA)/ Prof. dr. T.K. Sixma till November 2013, prof. dr. Academic Medical Center (AMC) H. te Riele from November 2013 Meibergdreef 15 Dr. M. Spaargaren 1105 AZ Amsterdam phone : 020-5668502 fax : 020-5669165 Netherlands Cancer Institute (NKI) Contact / secretariat: Ms. P. Lagerweij Plesmanlaan 121 1066 CX Amsterdam phone : 020-512 6973 fax : 020-512 1944 email : [email protected] Faculty and staff The complete list of founding institutes’ faculty and staff involved in educational activities and research projects conducted by OOA is provided in Annex 1. Board and organization - 11 12 – Board and organization Oncology Graduate School Amsterdam OOA general report 2 2. General report Educational activities understanding of tumor development, progression and therapy resistance. Candidate markers are The OOA is a successful and large graduate school, tested for their ability to predict/detect cancer at with 507 PhD students, 117 faculty members an early stage. Disease profiling is being improved involved. It is the only Dutch research school using innovative research tools. Tools applied in specifically focusing on training in cancer research. research projects include high-throughput methods Monitoring of the quality of research in the for (epi)genetic, transcriptomic and proteomic different institutes is performed by local analyses. Examples are large tumor cohort screens committees at the participating institutes, e.g. a with CGH or expression arrays, gain-of-function research institute or board. genetic screens with retroviral cDNA expression The quality of the OOA is shown by its regular libraries, and loss-of-function genetic screens with accreditation by the Royal Netherlands Academy of RNA interference libraries. Quantitative mass Sciences regularly, currently for the period 2009- spectrometry is being used to search for proteins 2014. to distinguish the diseased and disease-free states. Mechanistic studies using e.g. structural biology The core activity of OOA is training PhD students in complement the functional studies. Advanced conducting cancer research. For this purpose, OOA mouse models or sophisticated xenotransplant has developed a high-quality curriculum. In 2013, models have been developed for the genetic OOA organized various graduate training courses dissection of cancer. At cellular level, processes and an Annual Graduate Student Retreat. like cell-cell communication, adhesion, migration, survival, proliferation and differentiation are all All courses were evaluated by means of being studied. Furthermore, the mechanisms of standardized evaluation procedures. In this way, therapy resistance and metastasis are being OOA carefully monitors the quality of its courses. investigated. Based on the outcome of these evaluations, the Viral oncogenesis projects focus on the role of training programs are being improved continuously. human papilloma viruses and Epstein-Barr virus in the development of human cancer, by using both in A detailed description of all training courses vitro models and clinically well-defined patient offered in 2013 is provided in chapter 3 of this tumor samples. Viral and host markers are being Annual Report. tested for their capability to assess the risk associated with the development of cancer. Research program Theme 2: Experimental clinical Research projects at OOA’s institutes can be research clustered under two main themes. The theme Improvements in clinical care in oncology are 'Experimental biology' covers 'Oncogenesis' and based on improved detection, development of 'Tumor cell biology' as the main lines of research. innovative therapies and personalized treatment The second main theme is 'Experimental clinical strategies. The emerging and rapidly growing fields research' and covers 'Diagnosis of cancer' and of molecular imaging and genomics are providing 'Prevention and therapy of cancer'. Chapter 4 new opportunities to study the biology of a provides listings of all individual PhD projects malignancy in individual patients and thus allowing conducted within these main themes. More for the development of highly valuable indicators detailed descriptions of these research programs for diagnosis and prediction of disease outcome. and their output are provided in the annual reports The development of the 70-gene breast cancer of the founding institutes. predictor at the NKI has led to the first FDA- approved diagnostic screen for breast cancer. Modern state-of-the-art techniques like MRI, Theme 1: Experimental biology SPECT, PET and PET/CT are enabling imaging The transformation of a normal cell into a methods with high precision and unique molecular malignant tumor cell requires multiple (epi)genetic and biological information at the tissue level. alterations affecting genes that control cellular (Molecular) reporter probes are being developed pathways. Studying the genes and proteins and evaluated. Highly developed mouse models are involved in these pathways results in better being used to follow drug sensitivity in several General report - 15 types of cancer and for developing clinical OOA has an excellent (inter)national status, as strategies for imaging. Targeted cancer therapy is demonstrated by the large number of research yet another research focus. Personalized therapy projects granted in open national and international should ensure optimal treatment benefits. Projects calls, including several of the prestigious new include (pre)clinical evaluations of the use of grants. The faculty is strongly represented in the neoadjuvant treatment or the application of new ‘vernieuwingsimpuls’, the Veni-Vidi-Vici molecular therapies and anti-angiogenic agents development grants for junior researchers and against novel targets in tumor and its environment. participates widely in CTMM projects and TI The pharmacological optimization of conventional Pharma projects as well as in numerous EU cytotoxic drugs is an important line of research, as integrated projects and networks of excellence. is the passage of drugs through the blood-brain Funding is also strongly supported by the Dutch barrier. Development of immunotherapies based on science foundation NWO and the cancer society, adoptive transfer and vaccination strategies are at KWF. the forefront of research. These, as well as novel targeted (anti-angiogenic) therapies and gene therapy
Recommended publications
  • Merlyn.AI Prudent Investing Just Got Simpler and Safer
    Merlyn.AI Prudent Investing Just Got Simpler and Safer by Scott Juds October 2018 1 Merlyn.AI Prudent Investing Just Got Simpler and Safer We Will Review: • Logistics – Where to Find Things • Brief Summary of our Base Technology • How Artificial Intelligence Will Help • Brief Summary of How Merlyn.AI Works • The Merlyn.AI Strategies and Portfolios • Importing Strategies and Building Portfolios • Why AI is “Missing in Action” on Wall Street? 2 Merlyn.AI … Why It Matters 3 Simply Type In Logistics: Merlyn.AI 4 Videos and Articles Archive 6 Merlyn.AI Builds On (and does not have to re-discover) Other Existing Knowledge It Doesn’t Have to Reinvent All of this From Scratch Merlyn.AI Builds On Top of SectorSurfer First Proved Momentum in Market Data Merlyn.AI Accepts This Re-Discovery Not Necessary Narasiman Jegadeesh Sheridan Titman Emory University U. of Texas, Austin Academic Paper: “Returns to Buying Winners and Selling Losers: Implications for Stock Market Efficiency” (1993) Formally Confirmed Momentum in Market Data Merlyn.AI Accepts This Re-Discovery Not Necessary Eugene Fama Kenneth French Nobel Prize, 2013 Dartmouth College “the premier market anomaly” that’s “above suspicion.” Academic Paper - 2008: “Dissecting Anomalies” Proved Signal-to-Noise Ratio Controls the Probability of Making the Right Decision Claude Shannon National Medal of Science, 1966 Merlyn.AI Accepts This Re-Discovery Not Necessary Matched Filter Theory Design for Optimum J. H. Van Vleck Signal-to-Noise Ratio Noble Prize, 1977 Think Outside of the Box Merlyn.AI Accepts This Re-Discovery Not Necessary Someplace to Start Designed for Performance Differential Signal Processing Removes Common Mode Noise (Relative Strength) Samuel H.
    [Show full text]
  • By Scott Juds – Sumgrowth Strategies
    AAII Phoenix Chapter by Scott Juds –PresentedSumGrowth by ScottStrategies Juds – Sept. 2019 December 12, 2019 President & CEO, SumGrowth Strategies 1 Disclaimers • DO NOT BASE ANY INVESTMENT DECISION SOLELY UPON MATERIALS IN THIS PRESENTATION • Neither SumGrowth Strategies nor I are a registered investment advisor or broker-dealer. • This presentation is for educational purposes only and is not an offer to buy or sell securities. • This information is only educational in nature and should not be construed as investment advice as it is not provided in view of the individual circumstances of any particular individual. • Investing in securities is speculative. You may lose some or all of the money that is invested. • Past results of any particular trading system are not guarantee indicative of future performance. • Always consult with a registered investment advisor or licensed stock broker before investing. 2 Merlyn.AI Prudent Investing Just Got Simpler and Safer The Plan: • Brief Summary of our Base Technology • How Artificial Intelligence Will Help • A Summary of How Merlyn.AI Works • The Merlyn.AI Strategies and Portfolios • Using Merlyn.AI within Sector Surfer • Let’s go Live Online and See How Things Work 3 Company History 2010 2017 2019 Merlyn.AI Corp. News Founded Jan 2019, Raised $2.5M, Exclusive License from SGS to Create & Market Merlyn ETFs Solactive US Bank RBC Calculator Custodian Publisher Market Maker Alpha Architect SGS Merlyn.AI ETF Advisor SectorSurfer SGS License Exemptive Relief NYSE AlphaDroid Investors Web Services MAI Indexes ETF Sponsor Compliance Quasar Marketing Distributor Cable CNBC Mktg. Approval Advisor Shares SEC FINRA G.Adwords Articles First Proved Momentum in Market Data Narasiman Jegadeesh Sheridan Titman Emory University U.
    [Show full text]
  • Information Book Overview
    ANR ABSTRACT BOOK Umschlag:Layout 1 05.05.14 13:48 Seite 2 ADVANCES IN NEUROBLASTOMA RESEARCH ANR CONGRESS 13TH – 16TH MAY 2014 COLOGNE, GERMANY INFORMATION BOOK OVERVIEW. PROGRAM. ABSTRACTS. ANR ABSTRACT BOOK Umschlag:Layout 1 05.05.14 13:49 Seite 3 ANR ABSTRACT BOOK Umschlag:Layout 1 05.05.14 13:51 Seite 4 Monday, May 12th Tuesday, May 13th Wednesday, May 14th Thursday, May 15th Friday, May 16th 08:00 08:00 08:00 08:00 08:00 08:15 08:15 08:15 08:15 08:15 Consortium of 08:30 08:30 08:30 Welcome address Congress Saal 08:30 Keynote 2 08:30 Parallel A6 Neuroblastoma 08:45 08:45 08:45 Keynote 1 08:45 Epigenetics in Neuroblastoma 08:45 Basic Research, Parallel B6 Foundations - Crest Development Congress Saal 09:00 09:00 09:00 09:00 09:00 Translational Research, Clinical Research III Medical Advisory Update Course Congress Saal 09:15 09:15 09:15 09:15 09:15 Clinical Research II 09:30 09:30 Board INRG UHRG 09:30 09:30 09:30 Europasaal Plenary 3 Offenbachsaal 09:45 09:45 09:45 Plenary 1 09:45 09:45 Translational Research II Europasaal 10:00 10:00 Conference Conference 10:00 Basic Research I 10:00 10:00 Workshop 1 Clinical Research I 10:15 10:15 Rooms 3/4/5 Room 1 10:15 Congress Saal 10:15 10:15 Drug Discovery Congress Saal Break/Coffee 10:30 10:30 Break/Coffee 10:30 10:30 10:30 10:45 10:45 and Development 10:45 10:45 10:45 for Break/Coffee 11:00 11:00 Break/Coffee 11:00 11:00 11:00 Parallel A7 Neuroblastoma Break/Coffee Parallel B7 11:15 11:15 Update Course 11:15 11:15 11:15 Translational Research: 11:30 11:30 11:30 Plenary 2 11:30 11:30 Clinical Research IV (cont.) Offenbachsaal Parallel A3 Molecular Markers 11:45 11:45 11:45 Basic Research II 11:45 Parallel B3 11:45 Europasaal Basic Research: 12:00 12:00 12:00 Translational Research I 12:00 Translational Research: 12:00 Offenbachsaal Oncogenesis III Europasaal Congress Saal Preclin.
    [Show full text]
  • Use of Attribute Driven Incremental Discretization and Logic Learning
    Cangelosi et al. BMC Bioinformatics 2014, 15(Suppl 5):S4 http://www.biomedcentral.com/1471-2105/15/S5/S4 RESEARCH Open Access Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients Davide Cangelosi1, Marco Muselli2†, Stefano Parodi2, Fabiola Blengio1, Pamela Becherini1, Rogier Versteeg3, Massimo Conte4, Luigi Varesio1*† From Tenth Annual Meeting of the Italian Society of Bioinformatics (BITS) Udine, Italy. 21-23 May 2013 Abstract Background: Cancer patient’s outcome is written, in part, in the gene expression profile of the tumor. We previously identified a 62-probe sets signature (NB-hypo) to identify tissue hypoxia in neuroblastoma tumors and showed that NB-hypo stratified neuroblastoma patients in good and poor outcome [1]. It was important to develop a prognostic classifier to cluster patients into risk groups benefiting of defined therapeutic approaches. Novel classification and data discretization approaches can be instrumental for the generation of accurate predictors and robust tools for clinical decision support. We explored the application to gene expression data of Rulex, a novel software suite including the Attribute Driven Incremental Discretization technique for transforming continuous variables into simplified discrete ones and the Logic Learning Machine model for intelligible rule generation. Results: We applied Rulex components to the problem of predicting the outcome of neuroblastoma patients on the bases of 62 probe sets NB-hypo gene expression signature. The resulting classifier consisted in 9 rules utilizing mainly two conditions of the relative expression of 11 probe sets. These rules were very effective predictors, as shown in an independent validation set, demonstrating the validity of the LLM algorithm applied to microarray data and patients’ classification.
    [Show full text]
  • (GAN) Technique for Internet of Medical Things Data
    sensors Article A Generative Adversarial Network (GAN) Technique for Internet of Medical Things Data Ivan Vaccari 1,* , Vanessa Orani 1 , Alessia Paglialonga 2 , Enrico Cambiaso 1 and Maurizio Mongelli 1 1 Consiglio Nazionale delle Ricerche (CNR), Institute of Electronics, Information Engineering and Telecommunications (IEIIT), 16149 Genoa, Italy; [email protected] (V.O.); [email protected] (E.C.); [email protected] (M.M.) 2 Consiglio Nazionale delle Ricerche (CNR), Institute of Electronics, Information Engineering and Telecommunications (IEIIT), 20133 Milan, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-010-6475-215 Abstract: The application of machine learning and artificial intelligence techniques in the medical world is growing, with a range of purposes: from the identification and prediction of possible diseases to patient monitoring and clinical decision support systems. Furthermore, the widespread use of remote monitoring medical devices, under the umbrella of the “Internet of Medical Things” (IoMT), has simplified the retrieval of patient information as they allow continuous monitoring and direct access to data by healthcare providers. However, due to possible issues in real-world settings, such as loss of connectivity, irregular use, misuse, or poor adherence to a monitoring program, the data collected might not be sufficient to implement accurate algorithms. For this reason, data augmentation techniques can be used to create synthetic datasets sufficiently large to train machine learning models. In this work, we apply the concept of generative adversarial networks (GANs) to perform a data Citation: Vaccari, I.; Orani, V.; augmentation from patient data obtained through IoMT sensors for Chronic Obstructive Pulmonary Paglialonga, A.; Cambiaso, E.; Disease (COPD) monitoring.
    [Show full text]
  • Detecting Hospital-Acquired Infections in Swedish Patient Records, and According to Our Experiments, They Lead to Encouraging Results
    JHI0010.1177/1460458216656472Health Informatics JournalKoffel et al. 656472research-article2016 Article Health Informatics Journal 2018, Vol. 24(1) 3 –13 A randomized controlled pilot © The Author(s) 2016 Reprints and permissions: study of CBT-I Coach: Feasibility, sagepub.co.uk/journalsPermissions.nav https://doi.org/10.1177/1460458216656472DOI: 10.1177/1460458216656472 acceptability, and potential impact journals.sagepub.com/home/jhi of a mobile phone application for patients in cognitive behavioral therapy for insomnia Erin Koffel Minneapolis Veteran Affairs Health Care System, USA; University of Minnesota Medical School, USA Eric Kuhn National Center for PTSD (NCPTSD), Dissemination and Training (D&T) Division, USA; Department of Veterans Affairs Palo Alto Health Care System (VAPAHCS), USA Napoleon Petsoulis Widener University, USA Christopher R Erbes Minneapolis Veteran Affairs Health Care System, USA; University of Minnesota Medical School, USA Samantha Anders Hennepin County Medical Center, USA Julia E Hoffman and Josef I Ruzek National Center for PTSD (NCPTSD), Dissemination and Training (D&T) Division, USA; Department of Veterans Affairs Palo Alto Health Care System (VAPAHCS), USA Melissa A Polusny Minneapolis Veteran Affairs Health Care System, USA; University of Minnesota Medical School, USA Corresponding author: Erin Koffel, Center for Chronic Disease Outcomes Research, Minneapolis Veteran Affairs Health Care System, One Veterans Drive, Minneapolis, MN 55417, USA. Email: [email protected] 4 Health Informatics Journal 24(1) Abstract There has been growing interest in utilizing mobile phone applications (apps) to enhance traditional psychotherapy. Previous research has suggested that apps may facilitate patients’ completion of cognitive behavioral therapy for insomnia (CBT-I) tasks and potentially increase adherence. This randomized clinical trial pilot study (n = 18) sought to examine the feasibility, acceptability, and potential impact on adherence and sleep outcomes related to CBT-I Coach use.
    [Show full text]
  • A Comparative Evaluation of Machine Learning Algorithms: Binary Classification on Medical Data
    University of Piraeus Department of Digital Systems Piraeus, Greece A Comparative Evaluation of Machine Learning Algorithms: Binary Classification on Medical Data A master’s thesis for the postgraduate programme “Digital Systems and Services: Big Data and Analytics” Panagiotis Goumenakis ME1709 Supervisor Prof. Dr. Andriana Prentza Piraeus, September 2019 Abstract Nowadays Machine Learning (ML) has been well applied and recognised as an effective tool to handle a wide range of real situations, including medical implementations. As the amount of data in the field of healthcare grows year by year, there is a remarkable development in disease forecasting with the help of ML applications. From the prediction of epidemic outburst and several diseases to contributing with better means of labelling and storing healthcare data, implementation of ML in the field of healthcare indicates accurate results. This thesis focuses mainly on two major aspects of ML areas. Firstly, on analysing a medical dataset providing visualisations together with invaluable information on dataset’s variables. Secondly, it emphasizes on implementing the appropriate algorithms to execute binary classification in order to determine whether a person is labelled as infected or not infected based on feature values of the sample set. Choosing the most suitable approach is crucial as it could potentially improve the clinical decisions as well as patients’ survival time when applied to real world problems. The research is based on the mesothelioma disease dataset, allocated on the UCI repository, containing 324 examples with 35 attributes. Regarding the unsupervised learning part, in order to deduct results and conclusions, various ML classification algorithms are used to perform the analysis such as Decision Tree, Support Vector Machines (SVM), Naive Bayes Classifier, Logistic Regression, k Nearest Neighbours (kNN), and Artificial Neural Networks (ANN).
    [Show full text]
  • Università Di Bologna Soccer Coach Decision Support
    ALMA MATER STUDIORUM - UNIVERSITÀ DI BOLOGNA SCUOLA DI INGEGNERIA E ARCHITETTURA DIPARTIMENTO DI INFORMATICA - SCIENZA E INGEGNERIA CORSO DI LAUREA MAGISTRALE IN INGEGNERIA INFORMATICA TESI DI LAUREA in Intelligent Systems M SOCCER COACH DECISION SUPPORT SYSTEM CANDIDATO RELATORE: Gustavo Huatuco Santos Chiar.ma Prof.ssa Michela Milano Anno Accademico 2017/18 Sessione III To God ... Abstract L'azienda sportiva sta attraversando una gigantesca trasformazione digitale incentrata sulle immagini, tempo reale e analisi dati utilizzati nelle competizioni. I metodi di processo convenzionali nella gestione dello sport come il fitness, la salute, la esercitazione, lo sviluppo, la realizzazione di partite e i fondamenti sono tutti rivoluzionati dalla digitalizzazione dello sport. È sempre noto che è necessaria una metodologia digitale semplice per organizzare e costruire una strategia fattibile. Concordiamo che la soluzione sia una digitalizzazione sportiva cui evoluzione continua richiederebbe sfide così pervasive. La bontà della digitalizzazione degli sport ed atleti si basa su ciò che viene fatto con la raccolta di suoi dati. Il vantaggio competitivo va a coloro che possono produrre la massima intelligenza dei dati e agire tempestivamente. L'impatto su tutti gli caratteristiche delle operazioni della squadra sportiva è potenziale. I dati non prendono tutte le decisioni, ma consentono decisioni consapevoli. In queste circostanze e con una visione e predilezione per gli sport calcistici, abbiamo concepito un sistema di supporto decisionale, col nostro problema prospettivo di come un sistema di supporto decisionale per allenatori di calcio collabori con loro per prendere decisioni efficientemente. Per affrontare questo problema, elaboriamo un sistema di supporto alle decisioni degli allenatori di calcio. Il sistema è organizzato in due componenti combinati; la prima simula la predizione del vincitore della partita mediante una rete neurale guidata di dati.
    [Show full text]
  • Arxiv:1907.04708V1 [Cs.LG] 10 Jul 2019 1 Introduction
    Learning a Behavior Model of Hybrid Systems Through Combining Model-Based Testing and Machine Learning (Full Version)? Bernhard K. Aichernig, Roderick Bloem, Masoud Ebrahimi, Martin Horn, Franz Pernkopf, Wolfgang Roth, Astrid Rupp, Martin Tappler, and Markus Tranninger Graz University of Technology, Graz, Austria [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected], [email protected] Abstract. Models play an essential role in the design process of cyber- physical systems. They form the basis for simulation and analysis and help in identifying design problems as early as possible. However, the construction of models that comprise physical and digital behavior is challenging. Therefore, there is considerable interest in learning such hybrid behavior by means of machine learning which requires sufficient and representative training data covering the behavior of the physical system adequately. In this work, we exploit a combination of automata learning and model-based testing to generate sufficient training data fully automatically. Experimental results on a platooning scenario show that recurrent neural networks learned with this data achieved significantly better results com- pared to models learned from randomly generated data. In particular, the classification error for crash detection is reduced by a factor of five and a similar F1-score is obtained with up to three orders of magnitude fewer training samples. Keywords: Hybrid Systems · Behavior Modeling · Automata Learn- ing · Model-Based Testing · Machine Learning · Autonomous Vehicle · Platooning arXiv:1907.04708v1 [cs.LG] 10 Jul 2019 1 Introduction In Cyber Physical Systems (CPSs), embedded computers and networks control physical processes.
    [Show full text]
  • By Scott Juds 7 PM PST, 9-23-2019 Sumgrowth Strategies
    by Scott Juds 7 PM PST, 9-23-2019 SumGrowth Strategies by Scott Juds – SumGrowth Strategies – Sept. 2019 1 Disclaimers • DO NOT BASE ANY INVESTMENT DECISION SOLELY UPON MATERIALS IN THIS PRESENTATION • Neither SumGrowth Strategies nor I are a registered investment advisor or broker-dealer. • This presentation is for educational purposes only and is not an offer to buy or sell securities. • This information is only educational in nature and should not be construed as investment advice as it is not provided in view of the individual circumstances of any particular individual. • Investing in securities is speculative. You may lose some or all of the money that is invested. • Past results of any particular trading system are not a guarantee of future performance. • Always consult with a registered investment advisor or licensed stock broker before investing. 2 Also Show Client Account with AD Risk as it should Be Compare to S&P500 3 Also Show Client Account with AD Risk as it should Be Compare to S&P500 4 5 Merlyn.AI Builds On (and does not have to re-discover) Other Existing Knowledge It Doesn’t Have to Reinvent All of this From Scratch Formally Confirmed Momentum in Market Data Merlyn.AI Accepts This Re-Discovery Not Necessary Eugene Fama Kenneth French Nobel Prize, 2013 Dartmouth College “the premier market anomaly” that’s “above suspicion.” Academic Paper - 2008: “Dissecting Anomalies” Proved Signal-to-Noise Ratio Controls the Probability of Making the Right Decision Claude Shannon National Medal of Science, 1966 Merlyn.AI Accepts This Re-Discovery Not Necessary Matched Filter Theory Design for Optimum Signal-to-Noise Ratio J.
    [Show full text]
  • Translational Applications of Artificial Intelligence and Machine
    biomolecules Article Translational Applications of Artificial Intelligence and Machine Learning for Diagnostic Pathology in Lymphoid Neoplasms: A Comprehensive and Evolutive Analysis Julia Moran-Sanchez 1,2, Antonio Santisteban-Espejo 3,4,*, Miguel Angel Martin-Piedra 5, Jose Perez-Requena 3 and Marcial Garcia-Rojo 3,4 1 Division of Hematology and Hemotherapy, Puerta del Mar Hospital, 11009 Cadiz, Spain; [email protected] 2 Ph.D Program of Clinical Medicine and Surgery, University of Cadiz, 11009 Cadiz, Spain 3 Pathology Department, Puerta del Mar Hospital, 11009 Cadiz, Spain; [email protected] (J.P.-R.); [email protected] (M.G.-R.) 4 Institute of Research and Innovation in Biomedical Sciences of the Province of Cadiz (INiBICA), University of Cadiz, 11009 Cadiz, Spain 5 Tissue Engineering Group, Department of Histology, University of Granada, 18016 Granada, Spain; [email protected] * Correspondence: [email protected]; Tel.: +34-603470838 Abstract: Genomic analysis and digitalization of medical records have led to a big data scenario within hematopathology. Artificial intelligence and machine learning tools are increasingly used to Citation: Moran-Sanchez, J.; integrate clinical, histopathological, and genomic data in lymphoid neoplasms. In this study, we Santisteban-Espejo, A.; Martin-Piedra, identified global trends, cognitive, and social framework of this field from 1990 to 2020. Metadata M.A.; Perez-Requena, J.; Garcia-Rojo, were obtained from the Clarivate Analytics Web of Science database in January 2021. A total of M. Translational Applications of 525 documents were assessed by document type, research areas, source titles, organizations, and Artificial Intelligence and Machine countries. SciMAT and VOSviewer package were used to perform scientific mapping analysis.
    [Show full text]
  • 2301Gcwcbctu.Pdf
    内 容 简 介 随着人工智能热潮的兴起,企业对人工智能领域产品经理的人才需求也开始井喷,人工智 能产品经理成为顺应时代潮流的重要人力资源。实际上,人工智能确实给现有的产品和服务带 来了全方位的升级,这也给产品经理从业人员提出了更高的要求,是关注人工智能产品的产品 经理们面临的一次关键转型考验。 本书从知识体系、能力模型、沟通技巧等方面帮助大家系统地梳理了人工智能产品经理所 必备的基本素质和技能,旨在帮助产品经理找到转型升级的最佳学习路线,以成为合格的人工 智能产品经理。 本书适合现阶段从事产品经理工作的人士转型做人工智能产品时学习,也适合以人工智能 产品经理为职业理想的人士阅读。另外,人工智能领域的企业负责人和技术骨干也适合阅读本 书,以了解企业的技术人才需求。 未经许可,不得以任何方式复制或抄袭本书之部分或全部内容。 版权所有,侵权必究。 图书在版编目(CIP)数据 人工智能产品经理:AI 时代 PM 修炼手册 / 张竞宇著. —北京:电子工业出版社,2018.6 ISBN 978-7-121-33914-1 Ⅰ. ①人… Ⅱ. ①张… Ⅲ. ①人工智能-研究 Ⅳ.①TP18 中国版本图书馆 CIP 数据核字(2018)第 060962 号 责任编辑:林瑞和 印 刷: 装 订: 出版发行:电子工业出版社 北京市海淀区万寿路 173 信箱 邮编:100036 开 本:720×1000 1/16 印张:13.25 字数:198 千字 版 次:2018 年 6 月第 1 版 印 次:2018 年 6 月第 1 次印刷 定 价:59.00 元 凡所购买电子工业出版社图书有缺损问题,请向购买书店调换。若书店售缺,请与本社发 行部联系,联系及邮购电话:(010)88254888,88258888。 质量投诉请发邮件至 [email protected],盗版侵权举报请发邮件至 [email protected]。 本书咨询联系方式:010-51260888-819,[email protected]。 前言 伴随着科技的迅猛发展,近些年人工智能(Artificial Intelligence, AI)的浪潮席卷 了全球各个角落,异常活跃的学术界,以及每个人生活中都带有人工智能技术的服务 和产品体验,无不印证了这个事实。不少科技界的大牛都认为这次科技变革无论是从 影响的深度还是广度上,都会比互联网给人类带来的变革更深远,有些媒体甚至称这 次科技变革是另外一种形态的“工业革命”。 随着人工智能热潮迭起,企业对人才的需求也井喷了。根据招聘网站的大数据统 计,人工智能人才的薪酬普遍高于普通 IT 从业人员的平均薪酬,尤其是算法工程师 的薪酬,更是居高不下。当前市场已经形成企业抢夺人工智能人才的局面。 然而伴随着资本源源不断涌入市场和人工智能创业热情不断提升,企业对于人工 智能的认知及对于人才的评价和识别能力,还处于非常有限的阶段。很多企业招聘时 都出现过职位与要求不匹配的情况——招聘人工智能专家、人工智能科学家,但技能 需求却基本上都是这样写的:“负责机器学习、深度学习领域的技术研发工作,包括 但不限于神经元网络设计与优化、数据降维、特征提取、分类聚类等。”事实上,该 需求描述是针对算法工程师或者人工智能研发工程师的,而要招的人工智能专家和人 工智能科学家显然不可能只了解算法而已。 人工智能产品经理——AI 时代 PM 修炼手册 人工智能行业中的职业类型和内涵与互联网行业相比有不小的区别,因此企业和 猎头在对人工智能人才的分类和定位并没有明确认知的前提下盲目招聘,会给企业带 来很高的人力资源风险。 人工智能人才大体上可以被分为以下两类。 ● 一类是那些可以实现人工智能技术的工程师,例如算法工程师。根据所要解决
    [Show full text]